EFSA suspends novel food applications due to ‘data gaps and uncertainties’ 
The European Food Safety Authority (EFSA) has ‘stopped the clock’ on 19 novel food applications for CBD, pending new data. The EU authority says its scientists cannot currently establish the safety of CBD as a novel food due to data gaps and uncertainties about potential hazards related to CBD intake. The news follows the submission […]
Beyond the CBD list: Frequently asked questions.
The Food Standards Agency (FSA) published a list of permitted CBD products, and their manufacturers, on 31 March 2022. The emergence of the long awaited list has presented more questions to answer. We asked Laura Williamson, Technical Advisor to the Association for the Cannabinoid Industry, to clear up some of the biggest issues. What led […]
FSA update: Rebranding, new products and novel food applications. What does the future hold for white labelled CBD?
The Food Standards Agency (FSA) has doubled down on its novel foods guidance for white labelled CBD oils, edibles and beverages. They say no brands launched after 13 February 2020 are permitted to enter the UK market without full novel foods authorisation. The FSA, which is responsible for protecting public health in relation to food […]
FSA issues clarification and new deadline for toxicology data
A number of CBD companies have until 28 February to provide sufficient toxicology data to the Food Standards Agency, or risk losing the right to sell their products. Cannabinoid Insight has learnt that up to 40 CBD companies which submitted summary data on epilepsy drug Epidiolex in their novel foods application, have until 28 February […]
